Rapamycin & Metformin
The most promising longevity drugs
Two existing drugs — rapamycin and metformin — have shown remarkable anti-aging effects in studies. Both are already FDA-approved for other conditions.
Rapamycin: the mTOR inhibitor
Discovered in Easter Island soil, rapamycin inhibits mTOR — the growth pathway that accelerates aging when chronically active. It extends lifespan in every organism tested.
Rapamycin's journey
Trace the remarkable history of rapamycin.
Rapamycin vs Metformin
Compare these two longevity drug candidates.
True or False
Metformin is only useful for people with diabetes.
Which of these are real, published effects of rapamycin?
Select every confirmed biological effect.
The TAME trial
TAME (Targeting Aging with Metformin) is the first FDA-approved clinical trial to test a drug specifically for aging. If successful, it could change how we regulate anti-aging medicine.
Key Takeaway
Rapamycin and metformin are the most promising longevity drugs in clinical research. Both target fundamental aging pathways, but self-medicating is risky — wait for trial results.